Here, investigation of pathological features and survival in a European cohort of HER2+ breast cancer patients with LM shows that preexisting brain metastases are common at LM diagnosis, affecting as many as two‐thirds of patients. This evidence concerns the gene ERBB2 and breast carcinoma.